Tech Company Financing Transactions
QuatRx Pharmaceuticals Funding Round
MPM Capital, Frazier Healthcare Partners and InterWest Partners joined a $28 million Series C funding round for QuatRx Pharmaceuticals. The financing round closed on 6/10/2003.
Transaction Overview
Company Name
Announced On
6/10/2003
Transaction Type
Venture Equity
Amount
$28,000,000
Round
Series C
Investors
MPM Capital (Lead Investor) (Nicholas Simon)
Proceeds Purpose
The Series C funds will be used to expand and advance QuatRx's product development programs.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
777 East Eisenhower Pkwy. 100
Ann Arbor, MI 48108
USA
Ann Arbor, MI 48108
USA
Phone
Website
Email Address
Overview
QuatRx Pharmaceuticals Company is a pharmaceutical company focused on discovering, licensing, developing and commercializing compounds in the endocrine, metabolic and cardiovascular therapeutic areas.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Robert Zerbe
Chief Financial Officer
Gary Onn
Chief Operating Officer
Christopher Nicholas
Chief Scientific Officer
Stuart Dombey
Browse more venture capital transactions:
Prev: 6/10/2003: TransPharma Medical venture capital transaction
Next: 6/11/2003: Trapeze Networks venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC investment data records on this site come from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs